Microfluidic Devices Market in the Healthcare Industry to 2015

2013-01-22
Published : Jan-2013

TechNavio”s analysts forecast the Global Microfluidic Devices market in the Healthcare industry to grow at a CAGR of 26.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing use of microfluidic devices in proteomics and genomics. The Global Microfluidic Devices market in the Healthcare industry has also been witnessing the trend of the increasing use of microfluidic devices in drug discovery. However, the intense competition among vendors could pose a challenge to the growth of this market.

TechNavio”s report, the Global Microfluidic Devices Market in the Healthcare Industry 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Monoclonal Antibodies market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Fluidigm Corp., RainDance Technologies Inc., Agilent Technologies Inc., and Dolomite Centre Ltd.

The other vendors mentioned in the report are Micronit Microfluidics BV, Illumina Inc., MicruX Technologies Inc., Abbott Laboratories, Boehringer Ingelheim GmbH, BioFluidix GmbH, Abaxis Inc., Advion Biosciences Inc., Caliper Life Sciences Inc., Cepheid Inc., Danaher Corp., Eksigent Technologies Inc., GE Novasensor Inc., Illumina Inc., Johnson and Johnson, Konica Minolta Holdings Inc., Microfluidic Systems Inc., Life Technologies Corp., Philips Healthcare, Roche Diagnostics, Shimadzu Biotech, and Siemens Healthcare.

Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio”s research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=212064.

Table of Contents

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Product Offerings
04. Market Landscape
Market Size and Forecast
04.1 Market Segmentation by Application
04.2 Five Forces Analysis
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and Their Impact
09. Market Challenges
10. Impact of Drivers and Challenges
11. Market Trends
12. Key Vendor Analysis
12.1 Fluidigm Corp.
Business Overview
Key Information
SWOT Analysis
12.2 RainDance Technologies Inc.
Business Overview
Key Information
SWOT Analysis
12.3 Agilent Technologies Inc.
Business Overview
Key Information
SWOT Analysis
12.4 Dolomite Centre Ltd.
Business Overview
Key Information
SWOT Analysis
13. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Microfluidic Devices Market in the Healthcare Industry 2011-2015 (US$ million)
Exhibit 2: Global Microfluidic Devices Market in the Healthcare Industry Segmentation by Application 2011
Exhibit 3: Global Microfluidic Devices Market in the Healthcare Industry Segmentation 2011-2015 (in percent)
Exhibit 4: Global Microfluidic Devices Market in the Healthcare Industry Segmentation 2011-2015 (in US$ million)
Exhibit 5: Global Microfluidic Devices Market in the Healthcare Industry by Vendor Segmentation (by revenue) 2011

Contact sales@reportsandreports.com for further information.

Filed in: Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Filtration Paper Market 2017-2021

Filtration, a technique used to separate solids from liquids, is the act of pouring a mixture onto a membrane (filter paper) that allows the passage of liquid (the filtrate) and results in the collection of the solid. The analysts forecast the global filtration paper market to grow at a CAGR of 4.16% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global filtration paper market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of filter papers. The market is divided into the following segments based on geography: APAC Europe North America ROW The report, Global Filtration Paper Market 2017-2021, has been prepared based on an in-depth mark......
$3500

Global Healthcare Cloud Computing Market 2017-2021

Cloud computing helps enterprises effectively reduce their capital and operational costs. It is gaining traction in the global healthcare industry as organizations are adopting an information-centric business approach. The demand for on-premises software solutions in the healthcare industry has receded due to the growing adoption of cloud-based solutions. Polycom, a US-based firm that manufactures video conferencing equipment, is offering cloud-based on-demand video conferencing solutions that help reduce on-premises infrastructure costs. Cloud-based telehealth services eliminate the need to install hardware and other infrastructure that is set up in hospitals and telecardiology centers. The analysts forecast global healthcare cloud computing market to grow at a CAGR of 21.24% during th......
$3500

Global Coagulation Testing Market 2017-2021

Coagulation testing helps measure the ability of blood to form a clot. Clotting occurs when blood converts from liquid to gel form. Coagulation tests are performed to analyze clotting disorders, such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving the quality of life of patients. The analysts forecast the global coagulation testing market to grow at a CAGR of 6.43% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global coagulation testing market for 2017-2021. To calculate the market size, the ......
$3500

Global Critical Care Therapeutics Market 2017-2021

About Critical Care Therapeutics Critical care or intensive care is the close monitoring and treatment given to individuals with acute, life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in an ICU or trauma center. Plasma is the fluid portion of the blood, in which all the blood cells are suspended. It makes up about 55% of the total volume of the blood. The other components such as red blood cell (RBC), white blood cell (WBC), and platelets together comprise the remaining 45% of the blood. Plasma is mainly made up of water, which accounts for about 91% of the total volume. The analysts forecast global critical care therapeutics market to grow at a CAGR of 3.62% during the period 201......
$3500

Global Foot Insoles Market 2017-2021

Due to its structural nature, the human foot is intended to walk on natural grounds and without the use of high heels. The unusual inclined position of the foot due to heels and often flat floor will result in damage to the foot and therefore, in the podalgia. Most humans are born with healthy feet. Damage to the feet predominantly develops with time. The causes are disposition, overweight, hard grounds, wrong footwear, sport injuries, rheumatic changes, circulatory disorders, and neuropathies. The analysts forecast global foot insoles market to grow at a CAGR of 6.64% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global foot insoles market for 2017-2021. To calculate the market size, the report considers......
$3500

Global Cancer Monoclonal Antibodies Market 2017-2021

The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics. The analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, This report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be......
$3500

Global Multiple Myeloma Drugs Market 2017-2021

Multiple myeloma is an abnormal growth and accumulation of plasma cells in the bone marrow leading to malignancy. This can be caused by the overproduction of monoclonal immunoglobulins such as IgG, IgA, IgD, or IgE; or Bence-Jones protein. Under normal conditions, stem cells develop into B lymphocytes, mature in the lymph nodes, and are transported throughout the body. On the entry of foreign substances into the body, these B-cells develop into plasma cells and produce immunoglobulins against the disease. However, in multiple myeloma, the B-cells are damaged and give rise to many malignant plasma cells that produce excessive immunoglobulins of a single type, which the body does not require. The analysts forecast the global multiple myeloma drugs market to grow at a CAGR of 9.19% during ......
$3500

Global Smart Healthcare Market 2016-2020

Smart healthcare is the integration of different healthcare delivery mechanisms. It makes use of electronic patient records and streamlining processes, which leads to improved quality of life by reducing the risks to health (by remote monitoring and checks) and improving the general well-being of people. Smart healthcare provides more patient-centric services that improves access to healthcare and are customized to individual patients' needs. The analysts forecast global smart healthcare market to grow at a CAGR of 24.55% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global smart healthcare market for 2016-2020. To calculate the market size, the report considers the revenue generated from solutions EHR, ......
$2500

Nurse Call System Market in the US 2016-2020

The NCS helps a caregiver and a patient to effectively communicate with each other and enhance patient care. In the US, individuals undergoing treatment in specialized healthcare facilities such as in SNFs, ALFs, and ACFs need constant attention and care. Hence, to provide 24/7 care to them, there is a need for a dedicated line of communication between patients and caregivers; NCS are used for this purpose. The analysts forecast nurse call system market in the US to grow at a CAGR of 14.18% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the nurse call system market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of NCS, including nurse call comp......
$2500

Global Pompe Disease Treatment Market 2016-2020

Lysosomal storage diseases (LSDs) are a group of progressive, autosomal recessive, and hereditary disorders characterized by the accumulation of specific substrates and variable age of onset and clinical symptoms. Pompe disease, a type of LSD, is caused by mutations in the GAA gene. These mutations inhibit the mechanism of action (MOA) of GAA; it is an enzyme responsible for catabolizing glycogen, resulting in accumulation of glycogen to toxic levels in the lysosomes of the cells. The buildup of glycogen in certain tissues and organs, especially in the muscles, hinders the normal functions of the organs. It can be further divided as adult-onset and infantile-onset Pompe diseases. As the disease is an autosomal recessive hereditary disorder, both parents are carriers and pass one copy of th......
$2500